151 related articles for article (PubMed ID: 22114490)
21. Differential effects of the combination of tyrosol with chlorhexidine gluconate on oral biofilms.
do Vale LR; Delbem A; Arias LS; Fernandes RA; Vieira A; Barbosa DB; Monteiro DR
Oral Dis; 2017 May; 23(4):537-541. PubMed ID: 28142218
[TBL] [Abstract][Full Text] [Related]
22. Cyclodextrin inclusion complex of racecadotril: effect of drug-β- cyclodextrin ratio and the method of complexation.
Semalty M; Panchpuri M; Singh D; Semalty A
Curr Drug Discov Technol; 2014 Jun; 11(2):154-61. PubMed ID: 24188445
[TBL] [Abstract][Full Text] [Related]
23. Preparation, Physicochemical Characterization and Anti-fungal Evaluation of Nystatin-Loaded PLGA-Glucosamine Nanoparticles.
Mohammadi G; Shakeri A; Fattahi A; Mohammadi P; Mikaeili A; Aliabadi A; Adibkia K
Pharm Res; 2017 Feb; 34(2):301-309. PubMed ID: 27928646
[TBL] [Abstract][Full Text] [Related]
24. Investigation of β-cyclodextrin-norfloxacin inclusion complexes. Part 2. Inclusion mode and stability studies.
Mendes C; Buttchevitz A; Barison A; Ocampos FM; Bernardi LS; Oliveira PR; Silva MA
Expert Rev Anti Infect Ther; 2015 Jan; 13(1):131-40. PubMed ID: 25488143
[TBL] [Abstract][Full Text] [Related]
25. Gallic acid/hydroxypropyl-β-cyclodextrin complex: Improving solubility for application on in vitro/ in vivo Candida albicans biofilms.
Teodoro GR; Gontijo AVL; Borges AC; Tanaka MH; Lima GMG; Salvador MJ; Koga-Ito CY
PLoS One; 2017; 12(7):e0181199. PubMed ID: 28700692
[TBL] [Abstract][Full Text] [Related]
26. Characterization and antifungal activity of chlorhexidine:β-cyclodextrin inclusion complexes.
Schoeffel AC; Morikava FS; Urban AM; Novatski A; Moraes GS; Matioli G; Ferrari PC; Neppelenbroek KH; Farago PV; Urban VM
Ther Deliv; 2023 Apr; 14(4):295-309. PubMed ID: 37401351
[TBL] [Abstract][Full Text] [Related]
27. Ternary Inclusion Complexes of Rifaximin with β-Cyclodextrin and Sodium Deoxycholate for Solubility Enhancement.
Kaur P; Rampal A; Singh Bedi PM; Bedi N
Curr Drug Discov Technol; 2015; 12(3):179-89. PubMed ID: 26279215
[TBL] [Abstract][Full Text] [Related]
28. Influence of β-cyclodextrin on the Properties of Norfloxacin Form A.
Chierentin L; Garnero C; Chattah AK; Delvadia P; Karnes T; Longhi MR; Salgado HR
AAPS PharmSciTech; 2015 Jun; 16(3):683-91. PubMed ID: 25511811
[TBL] [Abstract][Full Text] [Related]
29. Improving furosemide polymorphs properties through supramolecular complexes of β-cyclodextrin.
Garnero C; Chattah AK; Longhi M
J Pharm Biomed Anal; 2014 Jul; 95():139-45. PubMed ID: 24667568
[TBL] [Abstract][Full Text] [Related]
30. Drug product development and pharmacological evaluation of a sparingly soluble novel camptothecin analog for peroral administration.
Nekkanti V; Karatgi P; Paruchuri S; Pillai R
Drug Deliv; 2011 May; 18(4):294-303. PubMed ID: 21214430
[TBL] [Abstract][Full Text] [Related]
31. Inclusion complexation of nimesulide with beta-cyclodextrins.
Vavia PR; Adhage NA
Drug Dev Ind Pharm; 1999 Apr; 25(4):543-5. PubMed ID: 10194611
[TBL] [Abstract][Full Text] [Related]
32. Influence of the preparation method on the physicochemical properties of indomethacin and methyl-β-cyclodextrin complexes.
Rudrangi SR; Bhomia R; Trivedi V; Vine GJ; Mitchell JC; Alexander BD; Wicks SR
Int J Pharm; 2015 Feb; 479(2):381-90. PubMed ID: 25579867
[TBL] [Abstract][Full Text] [Related]
33. Impact of farnesol and Corsodyl
Černáková L; Jordao L; Bujdáková H
Oral Dis; 2018 Sep; 24(6):1126-1131. PubMed ID: 29667274
[TBL] [Abstract][Full Text] [Related]
34. Development of an ophthalmic formulation containing ciprofloxacin-hydroxypropyl-b-cyclodextrin complex.
Nijhawan R; Agarwal SP
Boll Chim Farm; 2003 Jun; 142(5):214-9. PubMed ID: 14526654
[TBL] [Abstract][Full Text] [Related]
35. Dissolution enhancement of cefdinir with hydroxypropyl-β-cyclodextrin.
Guo B; Zhong S; Li N; Li X; Yi J; Jin M
Drug Dev Ind Pharm; 2013 Nov; 39(11):1638-43. PubMed ID: 24087855
[TBL] [Abstract][Full Text] [Related]
36. Preparation and solid-state characterization of inclusion complexes formed between miconazole and methyl-beta-cyclodextrin.
Ribeiro A; Figueiras A; Santos D; Veiga F
AAPS PharmSciTech; 2008; 9(4):1102-9. PubMed ID: 18975116
[TBL] [Abstract][Full Text] [Related]
37. Improvement on dissolution rate of inclusion complex of Rifabutin drug with β-cyclodextrin.
Shanmuga Priya A; Sivakamavalli J; Vaseeharan B; Stalin T
Int J Biol Macromol; 2013 Nov; 62():472-80. PubMed ID: 24076034
[TBL] [Abstract][Full Text] [Related]
38. The physicochemical characteristics of freeze-dried scutellarin-cyclodextrin tetracomponent complexes.
Cao F; Guo J; Ping Q
Drug Dev Ind Pharm; 2005 Sep; 31(8):747-56. PubMed ID: 16221609
[TBL] [Abstract][Full Text] [Related]
39. Complex formation of chlorhexidine gluconate with hydroxypropyl-β-cyclodextrin (HPβCD) by proton nuclear magnetic resonance spectroscopy ((1)H NMR).
Onnainty R; Longhi MR; Granero GE
Carbohydr Res; 2011 Jun; 346(8):1037-46. PubMed ID: 21489411
[TBL] [Abstract][Full Text] [Related]
40. Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir.
Aleem O; Kuchekar B; Pore Y; Late S
J Pharm Biomed Anal; 2008 Jul; 47(3):535-40. PubMed ID: 18367363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
